GlassScriptPhysician profile
Kalil G Abdullah
NPI 1073892758
$3,959.10
in general payments reported to CMS, 2019-2025
9 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2021: $269 · 2023: $2,983 · 2024: $302 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,720 · Food and Beverage: $760 · Travel and Lodging: $35.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,720.00 |
| Food and Beverage | $760.44 |
| Travel and Lodging | $35.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medexus Pharma, INC. | $2,849.45 | 2023 | Gleolan |
| Monteris Medical Corporation | $464.15 | 2019-2023 | Neuroblate |
| Zap Surgical Systems, INC. | $283.08 | 2024 | Zap-X Treatment Planning Software, Zap-X Radiosurgery System, Zap-X Mv Imager |
| Stryker Corporation | $108.32 | 2023-2025 | Mako, Adherus Autospray Dural Sealant, Universal Neuro 3 |
| Viseon, INC. | $102.50 | 2025 | Maxview System - Lateral Set |
| Nx Development Corp. | $78.17 | 2021 | |
| Medtronic, INC. | $35.07 | 2025 | |
| Integra Lifesciences Corporation | $19.26 | 2023 | Codman Certas, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Novo Nordisk INC | $19.10 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalil Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.